Larvol Delta - Alector-Announces-Results-from-AL002-INVOKE2-Phase-2-Trial-in-Individuals-with-Early-Alzheimers-Disease-and-Provides-Business-Update

AL002 - Alector, AbbVie

https://www.globenewswire.com/news-release/2024/11/25/2987062/0/en/Alector-Announces-Results-from-AL002-INVOKE-2-Phase-2-Trial-in-Individuals-with-Early-Alzheimer-s-Disease-and-Provides-Business-Update.html

Nov 25, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next